Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19

Cancer patients are more susceptible to SARS-CoV-2 infection and generally have higher mortality rate. Anti-SARS-CoV-2 IgG is an important consideration for the patients in this COVID-19 pandemic. Recent researches suggested the rapid decay of anti-SARS-CoV-2 antibodies in the general population, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yongsheng, Yu, Jing, Li, Dan, He, Kai, Liu, Wenyang, Wang, Lin, Chen, Yeshan, Xie, Conghua, Wu, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405618/
https://www.ncbi.nlm.nih.gov/pubmed/34462453
http://dx.doi.org/10.1038/s41598-021-96195-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405618/
https://www.ncbi.nlm.nih.gov/pubmed/34462453
http://dx.doi.org/10.1038/s41598-021-96195-w

Ejemplares similares